Affiris will hold clinical trials of Alzheimer's vaccine in Europe

04/26/2010 | Google

Affiris said it will soon conduct clinical trials of AD02, a vaccine candidate for Alzheimer's disease, in six European countries. The Austrian biotech firm said the studies will evaluate the efficacy of the vaccine, which was developed with GlaxoSmithKline, and expects to have results by 2012.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA